Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
AstraZeneca
AZN
|
+$546M |
| 3 |
Meta Platforms (Facebook)
META
|
+$526M |
| 4 |
Microsoft
MSFT
|
+$521M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$386M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$494M |
| 2 |
SNDK
Sandisk
SNDK
|
+$482M |
| 3 |
Honeywell
HON
|
+$365M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$362M |
| 5 |
EA
Electronic Arts
EA
|
+$345M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.17% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Healthcare | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Ranger Energy Services
RNGR
$381M
| $22M | ﹤0.01% |
1,372,488
+99,380
| +8% | +$1.63M |
|
2002
QuidelOrtho
QDEL
$767M
| $22M | ﹤0.01% |
1,253,683
-1,795,085
| -59% | -$23.7M |
|
|
KRMN
2003
Karman Holdings
KRMN
$5.01B
| $21.9M | ﹤0.01% |
439,396
+392,015
| +827% | +$25.3M |
|
2004
iRadimed
IRMD
$1.08B
| $21.9M | ﹤0.01% |
229,340
+3,194
| +1% | +$291K |
|
2005
Zillow
ZG
$7.29B
| $21.9M | ﹤0.01% |
698,550
+144,090
| +26% | +$5.57M |
|
2006
Protagonist Therapeutics
PTGX
$9.41B
| $21.8M | ﹤0.01% |
178,152
-329,951
| -65% | -$34.5M |
|
|
HUT
2007
Hut 8
HUT
$12B
| $21.8M | ﹤0.01% |
188,492
-19,127
| -9% | -$1.85M |
|
|
GRDN
2008
Guardian Pharmacy Services
GRDN
$2.98B
| $21.6M | ﹤0.01% |
516,094
+307,500
| +147% | +$11.9M |
|
2009
Huazhu Hotels Group
HTHT
$13.2B
| $21.5M | ﹤0.01% |
514,393
-24,662
| -5% | -$1.18M |
|
2010
Titan Machinery
TITN
$572M
| $21.4M | ﹤0.01% |
1,013,671
-87,842
| -8% | -$1.8M |
|
2011
Sabesp
SBS
$18.7B
| $21.4M | ﹤0.01% |
3,693,536
+82,021
| +2% | +$497K |
|
2012
Grindr
GRND
$2.69B
| $21.3M | ﹤0.01% |
1,484,079
+87,957
| +6% | +$1.14M |
|
2013
Artivion
AORT
$1.21B
| $21.3M | ﹤0.01% |
947,941
-79,634
| -8% | -$2.23M |
|
2014
Rocky Brands
RCKY
$325M
| $21.2M | ﹤0.01% |
514,294
+8,815
| +2% | +$344K |
|
2015
Parke Bancorp
PKBK
$406M
| $21.2M | ﹤0.01% |
639,022
+39,813
| +7% | +$1.22M |
|
2016
Viking Therapeutics
VKTX
$3.52B
| $21.1M | ﹤0.01% |
540,053
-2,463
| -0.5% | -$79.6K |
|
|
EXK
2017
Endeavour Silver
EXK
$2.95B
| $21M | ﹤0.01% |
+2,538,379
| New | +$23.6M |
|
2018
ACNB Corp
ACNB
$661M
| $21M | ﹤0.01% |
353,663
+18,819
| +6% | +$1.01M |
|
2019
BayCom
BCML
$333M
| $21M | ﹤0.01% |
637,001
+19,144
| +3% | +$586K |
|
2020
Third Coast Bancshares
TCBX
$745M
| $20.9M | ﹤0.01% |
517,513
+44,705
| +9% | +$1.74M |
|
|
CCRN
2021
DELISTED
Cross Country Healthcare
CCRN
| $20.8M | ﹤0.01% |
1,576,825
-33,100
| -2% | -$392K |
|
2022
STRATTEC Security
STRT
$269M
| $20.7M | ﹤0.01% |
253,733
+5,597
| +2% | +$426K |
|
2023
RLJ Lodging Trust
RLJ
$1.67B
| $20.6M | ﹤0.01% |
1,742,076
+232,258
| +15% | +$2.17M |
|
2024
Pangaea Logistics
PANL
$547M
| $20.5M | ﹤0.01% |
3,159,589
+275,119
| +10% | +$2.09M |
|
2025
Limbach Holdings
LMB
$644M
| $20.4M | ﹤0.01% |
264,780
-991
| -0.4% | -$82.4K |
|
Similar funds
Dimensional Fund Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Dimensional Fund Advisors held 3,315 positions worth $552B, up 15% from $481B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q2 2026 filing shows 100 new, 1,949 increased, 1,085 reduced and 94 closed positions. Its largest new stake was AstraZeneca: 2,904,886 shares worth $551M. The largest sale was Advanced Micro Devices, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2026 buy was AstraZeneca: 2,904,886 shares worth $551M.
- Dimensional Fund Advisors added most to Amazon in Q2 2026, an estimated $747M increase.
- Dimensional Fund Advisors's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $494M.
- Dimensional Fund Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $362M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $552B portfolio in Q2 2026.
- Dimensional Fund Advisors opened 100 new positions and closed 94 in Q2 2026.
- Dimensional Fund Advisors's portfolio value rose 15% quarter-over-quarter to $552B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.